The CRAFITY score to predict hepatocellular carcinoma disease control rate at month 12 in patients undergoing transarterial chemoembolization

被引：0
|
作者：
Veelken, Rhea [1 ]
Olbrich, Anne [1 ]
Lieb, Sabine [1 ]
Schindler, Aaron [1 ]
Herber, Adam [1 ]
Ebel, Sebastian [2 ]
Denecke, Timm [2 ]
Berg, Thomas [1 ]
van Bommel, Florian [1 ]
机构：
[1] Univ Hosp Leipzig, Div Hepatol, Dept Med 2, Leipzig, Germany
[2] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-501-YI
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [11] Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lin, Han-Chieh
    Chiang, Jen-Huey
    Lee, Pui-Ching
    Lee, Fa-Yauh
    Huo, Teh-Ia
    Lee, Shou-Dong
    LIVER INTERNATIONAL, 2010, 30 (01) : 77 - 84
  • [12] Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Ventura, Yossi
    Carr, Brian I.
    Kori, Issac
    Guerra, Vito
    Shibolet, Oren
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (15) : 1641 - 1649
  • [13] The CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy
    Zhou, Hai-Feng
    Yang, Wei
    Zhou, Wei-Zhong
    JOURNAL OF HEPATOLOGY, 2022, 76 (05) : 1232 - 1233
  • [14] ROLE OF ALBI SCORE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING TRANSARTERIAL CHEMOEMBOLIZATION IN CHILD-PUGH CLASS A AND LOW MELD SCORE
    Sohn, Won
    Kim, Jung Hee
    Oh, Hyun Woo
    Cho, Ju-Yeon
    Jeong, Jae Yoon
    Cho, Yongkyun
    Kim, Byung Ik
    HEPATOLOGY, 2024, 80
  • [15] ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable?
    Wu, Jian
    Bai, Wei
    Han, Guohong
    Fan, Daiming
    JOURNAL OF HEPATOLOGY, 2014, 61 (01) : 176 - 177
  • [16] Assessment for Retreatment (ART) Score for Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
    Kudo, Masatoshi
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    HEPATOLOGY, 2014, 59 (06) : 2424 - 2425
  • [17] Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Wang, Hongyu
    Lin, Chuyang
    Fan, Wenzhe
    Zhang, Jiang
    Zhang, Yingqiang
    Yao, Wang
    Li, Jiaping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3433 - 3444
  • [18] The ALBI and p-ALBI grades predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization (TACE)
    Campani, C.
    Vitale, A.
    Dragoni, G.
    Aburas, S.
    Arena, U.
    Giannini, E. G.
    Trevisani, F.
    Marra, F.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 44 - 44
  • [19] The ALBI and p-ALBI grades predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization (TACE)
    Campani, C.
    Dragoni, G.
    Aburas, S.
    Vitale, A.
    Giannini, E. G.
    Trevisani, F.
    Marra, F.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S198 - S198
  • [20] Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Tez, Mesut
    Zulfikaroglu, Baris
    CANCER, 2008, 112 (12) : 2820 - 2821
12345